COMP <GO>
VNT vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Vontier Corporation Common Stock (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: VNT 7
— TMO 5
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $35.62 (-0.75%) • MKT CAP: $4.85B
balance-sheet
2.74
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VNT VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VNT | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.90% | 9.30% | +9.60 | VNT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.6x | 30.4x | -20.80 | VNT | /valuation <GO> |
| Free Cash Flow Yield | 9.09% | 2.40% | +6.69 | VNT | /fcf-yield <GO> |
| Operating Margin | 18.30% | 17.40% | +0.90 | VNT | /operating-margins <GO> |
| Net Profit Margin | 13.20% | 15.10% | -1.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 3.20% | 3.90% | -0.70 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.30% | 0.24% | +0.06 | VNT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.74 | 4.50 | -1.76 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.8 | 59.1 | +12.69 | VNT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.94 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.1x | 36.3x | -25.20 | VNT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.85B | $262.22B | -$257.37B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VNT REV | TMO REV | VNT GROSS % | TMO GROSS % | VNT FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.08B | $44.56B | 44.0% | 44.0% | $441.1M | $6.29B |
| FY 2024 | $2.98B | $42.88B | 44.0% | 44.0% | $344.8M | $7.27B |
| FY 2023 | $3.10B | $42.86B | 44.0% | 44.0% | $315.7M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VNT // BETA 0.94
TMO // BETA 0.94